Turn Therapeutics (TTRX) Retained Earnings (2024 - 2026)

Turn Therapeutics' Retained Earnings history runs 3 years deep, the most recent figure standing at -$23.4 million for Q1 2026.

• In Q1 2026, Retained Earnings changed N/A year-over-year to -$23.4 million; the TTM figure through Mar 2026 stood at -$23.4 million (changed N/A YoY), while the FY2025 annual figure was -$22.4 million, down 16.64% from the prior year.
• Retained Earnings was -$23.4 million for Q1 2026 at Turn Therapeutics, down from -$22.4 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of -$19.2 million in Q4 2024 to a low of -$23.4 million in Q1 2026.
• Historically, Retained Earnings has averaged -$21.9 million across 3 years, with a median of -$22.5 million in 2025.
• Biggest YoY gain for Retained Earnings was 16.64% in 2025; the steepest drop was 16.64% in 2025.
• A 3-year view of Retained Earnings shows it stood at -$19.2 million in 2024, then slipped by 16.64% to -$22.4 million in 2025, then fell by 4.34% to -$23.4 million in 2026.
• The last three Retained Earnings figures came in at -$23.4 million (Q1 2026), -$22.4 million (Q4 2025), and -$22.7 million (Q3 2025), per Business Quant data.